000 | 01447 a2200421 4500 | ||
---|---|---|---|
005 | 20250512090619.0 | ||
264 | 0 | _c19711116 | |
008 | 197111s 0 0 eng d | ||
022 | _a0007-1323 | ||
024 | 7 |
_a10.1002/bjs.1800580904 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAubrey, D A | |
245 | 0 | 0 |
_aThe effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy. _h[electronic resource] |
260 |
_bThe British journal of surgery _cSep 1971 |
||
300 |
_a648-52 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAcid Phosphatase _xblood |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Hypersensitivity |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOrgan Size |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 |
_aPregnanes _xadverse effects |
650 | 0 | 4 |
_aProgestins _xadverse effects |
650 | 0 | 4 |
_aProstate _xdiagnostic imaging |
650 | 0 | 4 |
_aProstatic Hyperplasia _xdrug therapy |
650 | 0 | 4 |
_aPyuria _xcomplications |
650 | 0 | 4 |
_aThyroid Gland _xdrug effects |
650 | 0 | 4 | _aUrinary Catheterization |
650 | 0 | 4 | _aUrography |
700 | 1 | _aKhosla, T | |
773 | 0 |
_tThe British journal of surgery _gvol. 58 _gno. 9 _gp. 648-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/bjs.1800580904 _zAvailable from publisher's website |
999 |
_c4111547 _d4111547 |